Total thyroidectomy (TT) with central lymph node dissection (CND) can decrease locoregional recurrence in patients with thyroid carcinoma.[1,2] Central lymph node metastasis has important prognostic values for accurate clinical staging and postoperative treatment.[3,4] Therefore, TT with CND is widely accepted for the treatment of thyroid carcinoma. However, TT with CND, especially with bilateral CND (BCND), is associated with high incidence of transient or permanent hypoparathyroidism. The primary causes of postoperative hypoparathyroidism are direct injury, devascularization, venous engorgement, or inadvertent excision of the parathyroid gland (PG).[7,8] Hypoparathyroidism is a major cause of prolonged outpatient follow-up and hospital care cost. In addition, the quality of life in patients with permanent hypoparathyroidism who require long-term calcium and vitamin D supplementation is seriously affected. Therefore, many surgeons are interested in finding risk factors to predict postoperative hypoparathyroidism and beginning treatment early to prevent serious complications.
Although numerous studies have looked for risk factors of hypoparathyroidism after thyroidectomy, the causative factors of the complication have not been completely defined. Paek et al reported that PG autotransplantation, BCND, gross extrathyroidal extension, and accidental PG resection were associated with postoperative hypoparathyroidism, whereas Cho et al found that female gender, extent of CND, and inadvertent parathyroidectomy were significant risk factors of transient hypoparathyroidism, and no factors correlated significantly with permanent hypoparathyroidism. In addition, the risk factors of hypoparathyroidism after TT with CND are still unknown. Therefore, the aim of the present study was to analyze the risk factors of hypoparathyroidism following TT with CND.
2 Patients and methods
All the patients with thyroid carcinoma who underwent at least TT with unilateral CND (UCND) in the Department of Thyroid Surgery, West China Hospital of Sichuan University between January 2013 and June 2016 were included retrospectively. All surgeries were performed by an experienced surgeon. Exclusion criteria included previous thyroid or parathyroid surgery, preoperative PGs dysfunction, multiple endocrine neoplasia 2A, lobectomy, TT, near-TT, and incomplete data. According to the postoperative serum levels of parathyroid hormone (PTH) within 6 months, the patients were divided into normal, transient hypoparathyroidism, and permanent hypoparathyroidism groups. All patients in our department were informed and agreed to follow-up meetings at least 6 months after surgery. The study was approved by the medical ethics committee of West China Hospital, Sichuan University.
2.2 Indications of TT with lymph node dissection
In our department, the indications for TT are as followed: high risk; bilateral or multifocal differentiated thyroid carcinomas (DTC); unilateral DTC with contralateral nodule(s); isthmus DTC; DTC > 4 cm (stage T3); DTC with extrathyroidal invasion (stages T3 and T4); pathologic variables including tall cell variant, diffuse sclerosis variant, solid variant, and follicular variant; DTC with bilateral central lymph node or lateral lymph node metastases; DTC with distant metastases; medullary thyroid carcinoma (MTC); and TERT promoter mutation. UCND is performed routinely in patients with papillary thyroid carcinoma (PTC). The indications for BCND include: bilateral PTC; isthmus PTC; PTC with stage T3 and T4; prelaryngeal and pretracheal lymph node metastases; bilateral central lymph node or lateral lymph node metastases; MTC; and TERT promoter mutation. UCND or BCND is performed in patients with follicular thyroid carcinoma if there are ipsilateral or bilateral central lymph node metastases. Lateral lymph node dissection (LND) is performed on patients with lateral lymph node metastases or MTC.
2.3 Surgical procedures
Surgical procedures of TT with lymph node dissection were described as previous. The use of carbon nanoparticles suspension (Lai Mei Pharmaceutical Co, Chongqing, China) was determined by the surgeon. Autotransplantation was performed when a PG was resected inadvertently or devascularized. If a PG could not be retained in situ, a small part was sent to intraoperative frozen biopsy and the remaining was wrapped in gauze which was soaked with normal saline solution. When the PG was ascertained, it was immediately chopped into 1 mm3 fragments and buried into several pockets in the sternocleidomastoid muscle. Intraoperative neuromonitoring (Medtronic NIM-Response 2.0) was applied to identify and protect recurrent laryngeal nerve.
2.4 Perioperative management
Perioperative management of all patients was standardized. Preoperative examinations included serum calcium, PTH, thyroid function, neck ultrasound, and laryngoscopy. Serum calcium and PTH were routinely tested 1 day, 30 days, and 6 months after surgery. Patients with symptomatic hypocalcemia were treated with oral or intravenous calcium supplementation. Postoperative hypoparathyroidism was defined as any drop in serum PTH below the normal limit (normal range, 1.6–6.9 pmol/L). Permanent hypoparathyroidism was defined as lack of recovery of serum PTH to the normal range within 6 months. If serum PTH returned to normal within 6 months, it was classified as transient hypoparathyroidism.
2.5 Data collection
All the data were collected retrospectively, including patient demographics, preoperative examination, pathological characteristics of the thyroid carcinoma, surgical details, PG autotransplantation, accidental PG resection (found in the surgical specimens by pathologists), postoperative examination, and complications.
2.6 Statistical analysis
The statistical analyses were conducted with SPSS computer software (version 21.0). Parametric continuous variables with values expressed as mean ± standard deviation. Statistical comparison between groups was calculated using the χ 2 test or Student t test. A multivariate analysis was performed by using logistic regression to identify the perioperative factors, which were considered to influence on postoperative hypoparathyroidism. The results of the multivariate analysis were expressed as odds ratio, 95% confidence interval, and P value. Statistical significance was set at P < .05.
Of the 1492 patients whose medical records were reviewed, 903 met the study criteria and were included in the present analysis (Fig. 1). Of the 903 patients, 649 were female and 254 were male. The mean age was 43.2 ± 13.9 years. Four patients were diagnosed as follicular thyroid carcinoma and 15 were diagnosed as MTC. The remaining patients were diagnosed as PTC. TT with UCND and TT with BCND were performed on 288 and 465 patients, respectively. A total of 121 patients underwent TT with BCND and unilateral LND, and 29 accepted TT with BCND and bilateral LND. Among the 903 patients, postoperative hypoparathyroidism occurred in 409 patients (45.3%), transient hypoparathyroidism in 399 patients (44.2%), and permanent hypoparathyroidism in 10 patients (1.1%).
In comparing patients with transient hypoparathyroidism and without hypoparathyroidism, univariate analysis revealed that transient hypoparathyroidism was more common in patients with female gender (P = .001), nonuse of carbon nanoparticles (P = .021), bilateral carcinoma (P = .013), cN1 stage (P = .007), accidental PG resection (P = .004), PG autotransplantation (P < .001), and BCND (P < .001) (Table 1). No statistically significant association was found for age, body mass index, comorbidity, preoperative serum levels of PTH and calcium, tumor location, largest tumor size, largest size of lymph nodes, multifocality, gross extrathyroidal extension, numbers of harvested and metastatic lymph nodes, and pN stage (all P > .05). Multivariate analysis demonstrated that female gender (P < .001), nonuse of carbon nanoparticles (P = .038), PG autotransplantation (P < .001), accidental PG resection (P = .004), and BCND (P = .003) were the independent risk factors of transient hypoparathyroidism (Table 2).
In comparing patients with permanent hypoparathyroidism and without hypoparathyroidism, factors found on univariate analysis that significantly increased the risk of permanent hypoparathyroidism were nonuse of carbon nanoparticles (P = .026), accidental PG resection (P = .006), and a tumor in the upper pole of thyroid gland (P = .030) (Table 1). After logistic regression analysis, nonuse of carbon nanoparticles (P = .041) and a tumor in the upper pole of thyroid gland (P = .031) were the significant factors that affected the development of permanent hypoparathyroidism (Table 2).
In comparing patients with permanent hypoparathyroidism and transient hypoparathyroidism, univariate analysis revealed that permanent hypoparathyroidism was more common than transient hypoparathyroidism for hypertension (P = .029), a tumor in the upper pole of thyroid gland (P = .016), and cN1 stage (P = .041). Multivariate analysis of the 3 factors revealed that patients with transient hypoparathyroidism were more likely to develop permanent hypoparathyroidism when they had hypertension (P = .026) and a tumor in the upper pole of thyroid gland (P = .010) (Table 2).
Hypoparathyroidism is the most common significant complication following TT with CND, with the reported incidence varying from 14% to 51.9% in patients with transient hypoparathyroidism and 0% to 16.2% in those with permanent hypoparathyroidism.[2,14,15] In the current study, the incidence of transient and permanent hypoparathyroidism were 44.2% and 1.1%, which is in line with previous studies. Various factors may cause the development of hypoparathyroidism following TT with CND. Numerous studies have investigated the possible risk factors of postoperative hypoparathyroidism,[10,11] some of which have been generally accepted. Nevertheless, establishing these risk factors remains a challenge.
The results of the present study revealed female gender, nonuse of carbon nanoparticles, PG autotransplantation, accidental PG resection, and BCND as significant risk factors for postoperative transient hypoparathyroidism. Nonuse of carbon nanoparticles and a tumor in the upper pole of thyroid gland were identified as significant risk factors for permanent hypoparathyroidism. In addition, patients with transient hypoparathyroidism were more likely to develop permanent hypoparathyroidism when they had hypertension and a primary tumor in the upper pole of thyroid gland.
In this study, females appeared to encounter postoperative transient hypoparathyroidism almost twice as frequently as males. Although female gender was reported as an independent risk factor for postoperative transient hypoparathyroidism,[11,16] the exact mechanisms underlying the gender disparity can only be speculated. Previous studies have reported that differences in gender may exist at a number of physiologic and anatomic levels. First, the gender difference may be related to the effects of sex steroids on PTH secretion. Second, patients of different genders may have various regulators of monoclonal proliferation and mitosis of PG tissue.[18,19] Third, anatomic and morphologic differences of PG may exist between male and female patients.[20,21] Therefore, this implies that females may benefit from earlier and possibly preoperative calcium supplementation to reduce the occurrence of hypocalcemic symptom.
Carbon nanoparticles suspension was firstly considered as a protective factor for transient and permanent hypoparathyroidism, which further confirms its effectiveness on PG protection. In recent years, many researches indicated that carbon nanoparticles suspension could significantly reduce the incidence of hypoparathyroidism after TT with CND.[12,22,23] Carbon nanoparticles could only pass through lymphatic capillaries rather than blood capillaries due to the difference in permeability. There are rich lymphatics and lymphatic capillaries in thyroid gland, whereas almost none within the PG. As a result, carbon nanoparticles suspension can make thyroid gland and the surrounding lymph nodes black-stained, but not for PGs, which facilitates lymph node dissection and PG preservation. Hence, we recommend application of carbon nanoparticles suspension during TT with CND, especially with BCND, to lower the incidence of postoperative hypoparathyroidism.
Whether PG autotransplantation can prevent postoperative hypoparathyroidism is still a controversial issue. At present, the general recommendation is firstly to preserve all PGs in situ during the surgical procedure. Autotransplantation is only performed as a remedial measure when a PG is resected inadvertently or devascularized. All authors agree that PG autotransplantation causes higher incidence of transient hypoparathyroidism, but some have proposed that it prevents postoperative permanent hypoparathyroidism in the long-term follow-up.[26,27] Some studies, however, reported that both PG autotransplantation and accidental parathyroidectomy increased the prevalence of transient and permanent hypoparathyroidism.[28,29] In the present study, we found that PG autotransplantation and accidental PG resection were closely correlated with transient hypoparathyroidism, which is in accordance with the previous studies. But the 2 factors were found no significant influence on the occurrence of permanent hypoparathyroidism. This finding can probably be explained by the fact that there is a strong association between permanent hypoparathyroidism and the number of autotransplanted and/or accidentally resected PGs.[13,30] Most patients in our study had autotransplantation and/or inadvertent resection of no more than 2 PGs. Precise surgical techniques are needed to try to preserve all the PGs in situ. Surgeons should take care not to unintentionally resect any of the PGs during CND. PGs should also be carefully searched in all surgical specimens before sending for pathologic examination.
Most literatures have shown that routine BCND is related to an increased incidence of postoperative transient and permanent hypoparathyroidism.[31,32] A previous study reported that the rates of transient and permanent hypoparathyroidism following TT with BCND were 51.9% and 16.2%, while they were 36.1% and 7% after TT with UCND (all P < .05). However, 1 study found no correlation between CND and hypoparathyroidism. In our study, multivariate analysis also revealed that BCND had no statistically significant relation with permanent hypoparathyroidism, which is contrary to the findings of the previous studies. The result may be attributed to the surgeon's experience, which has been regarded as the most important risk factor for postoperative complications after thyroidectomy.[10,33] For this reason, after careful consideration of benefit, TT with BCND should be better performed by an experienced surgeon.
Interestingly, gross extrathyroidal extension and the number of harvested lymph nodes were not associated with either transient or permanent hypoparathyroidism, whereas a tumor in the upper pole of thyroid gland was firstly identified as a risk factor of permanent hypoparathyroidism following TT with CND. This finding may probably be explained by the facts that more difficult to identify superior PGs, more direct invasion to superior PGs, and more difficult to preserve superior PGs in situ are noted when a primary tumor locates in the upper pole than other sites of thyroid gland. It is of interest to discover that transient hypoparathyroidism patients with hypertension tend to develop permanent hypoparathyroidism than nonhypertensive patients. Hypertension can affect angiogenesis and delay the healing process to vascular injury.[34,35] So, these patients may benefit from ameliorating the microcirculation to reduce the occurrence of permanent hypoparathyroidism.
In conclusion, this study provides potentially useful information to prevent the occurrence of hypoparathyroidism after TT with CND. We recommend combination precise surgical techniques with application of carbon nanoparticles suspension for in situ preservation of PGs in thyroid carcinoma patients, especially in females with hypertension and a tumor in the upper pole of thyroid gland. Autotransplantation is only performed when a PG is resected inadvertently or devascularized. TT with BCND should be performed by an experienced surgeon after careful consideration of the possible risks and benefits. If these risk factors verified in our study could be properly controlled, the patients would be managed more efficiently to reduce the incidence of hypoparathyroidism following TT with CND.
The authors thank the National Natural Science Fund (81502612) and Scientific Research Fund of Science and Technology Department of Sichuan Province (2016SZ0045) for the support.
. Wang TS, Cheung K, Farrokhyar F, et al. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol 2013;20:3477–83.
. Hall CM, Snyder SK, Maldonado YM, et al. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence. Surgery 2016;160:1049–58.
. Costa S, Giugliano G, Santoro L, et al. Role of prophylactic central neck dissection in cN0 papillary thyroid cancer. Acta Otorhinolaryngol Ital 2009;29:61–9.
. Laird AM, Gauger PG, Miller BS, et al. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. World J Surg 2012;36:1268–73.
. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–33.
. Shan CX, Zhang W, Jiang DZ, et al. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope 2012;122:797–804.
. Fahad Al-Dhahri S, Al-Ghonaim YA, Sulieman Terkawi A. Accuracy of postthyroidectomy parathyroid hormone and corrected calcium levels as early predictors of clinical hypocalcemia. J Otolaryngol Head Neck Surg 2010;39:342–8.
. Bliss RD, Gauger PG, Delbridge LW. Surgeon's approach to the thyroid gland: surgical anatomy and the importance of technique. World J Surg 2000;24:891–7.
. Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 2002;128:389–92.
. Paek SH, Lee YM, Min SY, et al. Risk factors of hypoparathyroidism following total thyroidectomy for thyroid cancer. World J Surg 2013;37:94–101.
. Cho JN, Park WS, Min SY. Predictors and risk factors of hypoparathyroidism after total thyroidectomy. Int J Surg 2016;34:47–52.
. Su AP, Wei T, Liu F, et al. Use of carbon nanoparticles to improve lymph nodes dissection and identification of parathyroid glands at thyroidectomy for papillary thyroid cancer. Int J Clin Exp Med 2016;9:19529–36.
. Song CM, Jung JH, Ji YB, et al. Relationship between hypoparathyroidism and the number of parathyroid glands preserved during thyroidectomy. World J Surg Oncol 2014;12:200.
. Henry JF, Gramatica L, Denizot A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998;383:167–9.
. Giordano D, Valcavi R, Thompson GB, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 2012;22:911–7.
. Sands NB, Payne RJ, Côté V, et al. Female gender as a risk factor for transient post-thyroidectomy hypocalcemia. Otolaryngol Head Neck Surg 2011;145:561–4.
. Sandelin K, Skoog L, Humla S, et al. Oestrogen, progesterone, and glucocorticoid receptors in normal and neoplastic parathyroid glands. Eur J Surg 1992;158:467–72.
. Almaden Y, Felsenfeld AJ, Rodriguez M, et al. Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender. Kidney Int 2003;64:2311–7.
. Naveh-Many T, Rahamimov R, Livni N, et al. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995;96:1786–93.
. Dufour DR, Wilkerson SY. Factors related to parathyroid weight in normal persons. Arch Pathol Lab Med 1983;107:167–72.
. Dekker A, Dunsford HA, Geyer SJ. The normal parathyroid gland at autopsy: the significance of stromal fat in adult patients. J Pathol 1979;128:127–32.
. Zhu Y, Chen X, Zhang H, et al. Carbon nanoparticle-guided central lymph node dissection in clinically node-negative patients with papillary thyroid carcinoma. Head Neck 2016;38:840–5.
. Li Y, Jian WH, Guo ZM, et al. A meta-analysis of carbon nanoparticles for identifying lymph nodes and protecting parathyroid glands during surgery. Otolaryngol Head Neck Surg 2015;152:1007–16.
. Huang K, Luo D, Huang M, et al. Protection of parathyroid function using carbon nanoparticles during thyroid surgery. Otolaryngol Head Neck Surg 2013;149:845–50.
. Li J, Li X, Wang Z. Negative developing of parathyroid using carbon nanoparticles during thyroid surgery. Gland Surgery 2013;2:100–1.
. Olson JA Jr, DeBenedetti MK, Baumann DS, et al. Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 1996;223:472–8.
. Ahmed N, Aurangzeb M, Muslim M, et al. Routine parathyroid autotransplantation during total thyroidectomy: a procedure with predictable outcome. J Pak Med Assoc 2013;63:190–3.
. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007;245:604–10.
. Sitges-Serra A, Ruiz S, Girvent M, et al. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg 2010;97:1687–95.
. Kihara M, Miyauchi A, Kontani K, et al. Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J Surg 2005;75:532–6.
. Carling T, Long WD, Udelsman R. Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol 2010;22:30–4.
. Roh JL, Park JY, Park CI. Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer 2009;115:251–8.
. Toniato A, Boschin IM, Piotto A, et al. Complications in thyroid surgery for carcinoma: one institution's surgical experience. World J Surg 2008;32:572–5.
. Hansen AH, Nielsen JJ, Saltin B, et al. Exercise training normalizes skeletal muscle vascular endothelial growth factor levels in patients with essential hypertension. J Hypertens 2010;28:1176–85.
. Gliemann L, Buess R, Nyberg M, et al. Capillary growth, ultrastructure remodelling and exercise training in skeletal muscle of essential hypertensive patients. Acta Physiol (Oxf) 2015;214:210–20.
Keywords:Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
central lymph node dissection; hypoparathyroidism; risk factor; total thyroidectomy